William D Smith Jr., CRNA Nurse Anesthetist, Certified Registered Medicare: Medicare Enrolled Practice Location: 727 Hospital Dr, Shelbyville, KY 40065 Phone: 502-647-4085 Fax: 502-647-4098 |
Chelsea Elizabeth Dresner, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 727 Hospital Dr, Shelbyville, KY 40065 Phone: 502-647-4085 Fax: 502-647-4098 |
Jerred Davis Mccarty, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 727 Hospital Dr, Shelbyville, KY 40065 Phone: 502-647-4085 Fax: 502-647-4098 |
Donald David Hart Ii, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 727 Hospital Dr, Shelbyville, KY 40065 Phone: 502-647-4085 Fax: 502-647-4098 |
Alexis Jayne Chambers, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 727 Hospital Dr, Shelbyville, KY 40065 Phone: 502-647-4085 Fax: 502-647-4098 |
Rosalie Spreen Gray, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 727 Hospital Dr, Shelbyville, KY 40065 Phone: 502-647-4085 Fax: 502-647-4098 |
Sarah Michelle Sanders, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 727 Hospital Dr, Shelbyville, KY 40065 Phone: 502-647-4085 Fax: 502-647-4098 |
News Archive
Meanwhile, The Hill reports that health lobbying has dropped off compared to the level a year ago when Congress was in the midst of the health reform debate.
NeurogesX, Inc. announced today that Qutenza® (capsaicin) 8% patch, the first and only product containing prescription-strength capsaicin, is now available. Clinical studies have shown that a single one-hour Qutenza application can provide three months relief from pain associated with postherpetic neuralgia, the nerve pain that can occur after shingles.
Today we congratulate the Centre for the AIDS Programme of Research in South Africa and the people of South Africa on the positive findings from the CAPRISA 004 microbicide study, which marks a significant milestone both for the microbicide research field and HIV prevention as a whole.
Momenta Pharmaceuticals, Inc., a biotechnology company specializing in the characterization and engineering of complex drugs, today reported its financial results for the fourth quarter and year ended December 31, 2010.
› Verified 6 days ago